Surprisingly, INFUSE sales growth is carrying Medtronic Spine

By

 
 
 
 
 
 
 
INFUSE SALES LEADING MEDTRONIC SPINE TO HEALTH (Orthopedics This Week)
Medtronic Inc.’s spine’s most recent quarter’s sales beat Wall Street expectations. Most surprisingly, Infuse is credited with causing the surprise.
Yes, you read that right. Biologic sales for Medtronic’s second quarter rose 9% on a reported basis while Core Spine and Interventional Spine, which consists of the company’s balloon kyphoplasty product line slipped 1% and 6%, respectively. Management said the company’s kyphoplasty sales were affected by a product supply issue r...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.